A copper(II)-selective chelator ameliorates left-ventricular hypertrophy in type 2 diabetic patients: a randomised placebo-controlled study.
Cooper GJ, Young AA, Gamble GD, Occleshaw CJ, Dissanayake AM, Cowan BR, Brunton DH, Baker JR, Phillips AR, Frampton CM, Poppitt SD, Doughty RN.
Diabetologia. 2009 Apr;52(4):715-22. Epub 2009 Jan 27.PMID: 19172243 [PubMed - indexed for MEDLINE]Related articles